ADVERTISEMENT
Advertise

Content

List volumes - List articles in this issue

Effects of Topical Corticosteroid and Tacrolimus on Ceramides and Irritancy to Sodium Lauryl Sulphate in Healthy Skin

doi: 10.2340/00015555-1064

Abstract:

The skin barrier, located in the stratum corneum, is influenced mainly by the lipid and protein composition of this layer. In eczematous diseases impairment of the skin barrier is thought to be of prime importance. Topical anti-inflammatory drugs and emollients are the most widely used eczema treatments. The aim of this study was to examine the effects of topically applied corticosteroid, tacrolimus and emollient on stratum corneum lipids and barrier parameters. Nineteen healthy volunteers participated in the study. Both forearms of the subjects were divided into four areas, which were treated twice daily for one week with betamethasone, tacrolimus, emollient, or left untreated, respectively. After one week each area was challenged with a 24 h sodium lauryl sulphate patch test. The lipids were collected using the cyanoacrylate method and evaluated by high performance thin layer chromatography. For evaluation of the skin barrier, transepidermal water loss, erythema and electrical capacitance were measured. The ceramide/cholesterol ratio was increased in betamethasone- (p = 0.008) and tacrolimus-treated (p = 0.025) skin compared with emollient-treated skin. No differences in ceramide subgroups were found between treatment regimes. Pretreatment with betamethasone (p = 0.01) or with tacrolimus (p = 0.001) causes a decreased inflammatory response to sodium lauryl sulphate compared with emollient. In conclusion, treatment with betamethasone and tacrolimus has a positive effect on the ceramide/cholesterol ratio and susceptibility to irritant reaction compared with an emollient.

Authors:

Jakob Mutanu Jungersted, Julie K. Høgh, Lars I. Hellgren, Gregor B.E. Jemec, Tove Agner

References

  1. Agner T. Skin susceptibility in uninvolved skin of hand eczema patients and healthy controls. Br J Dermatol 1991; 125: 140–146. [CrossRef]
  2. Holm EA, Wulf HC, Thomassen L, Jemec GB. Instrumental assessment of atopic eczema: validation of transepidermal water loss, stratum corneum hydration, erythema, scaling and edema. J Am Acad Dermatol 2006; 55: 772–780. [CrossRef]
  3. Jungersted JM, Hellgren LI, Jemec BGE, Agner T. Lipids and skin barrier function – a clinical perspective. Contact Dermatitis 2008; 58: 255–262. [CrossRef]
  4. Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol 2008; 17: 1063–1072. [CrossRef]
  5. Bleck O, Abeck D, Ring J, Hoppe J, Vietzke JP, Wolber R, et al. Two ceramide subfractions detectable in Cer(AS) position by HPTLC in skin surface lipids of non-lesional skin of atopic eczema. J Invest Dermatol 1991; 113: 894–900. [CrossRef]
  6. Nardo AD, Wertz P, Giannetti A, Seidenari S. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol 1998; 78: 27–30. [CrossRef]
  7. Yamamoto A, Serizawa S, Ito M, Sato Y. Stratum corneum lipid abnormalities in atopic dermatitis. Arch Dermatol Res 1991; 283: 219–223. [CrossRef]
  8. Jungersted JM, Scheer H, Mempel M, Baurecht H, Cifuentes L, Høgh JK, et al. Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema. Allergy 2010; 65: 911–918. [CrossRef]
  9. Schäfer-Korting M, Kleuser B, Ahmed M, Höltje HD, Kortling HC. Glucocorticoids for human skin: new aspects of the mechanism of action. Skin Pharmacol Physiol 2005; 18: 103–114. [CrossRef]
  10. El-Batawy MMY, Bosseila MAW, Mashaly HM, Hafez VSGA. Topical calcinurin inhibitors in atopic dermatitis: a systemic review and meta-analysis. J Dermatol Sci 2009; 54: 76–87. [CrossRef]
  11. Jensen JM, Pfeiffer S, Witt M, Bräutigam M, Neumann C, Weichenthal M, et al. Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis. J Allergy Clin Immunol 2009; 123: 1124–1133. [CrossRef]
  12. Kao JS, Fluhr JW, Man MQ, Fowler AJ, Hachem JP, Crumrine D, et al. Short-term glucocoid treatment comprises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities. J Invest Dermatol 2003; 120: 456–464. [CrossRef]
  13. Paslin D, Wertz P. A study to determine the effect of tacrolimus on ceramide levels in stratum corneum of patients with atopic dermatitis. Int J Dermatol 2006; 45: 352–356. [CrossRef]
  14. Buraczewska I, Berne B, Lindberg M, Törmä H, Lodén M. Changes in skin barrier function following long-term treatment with moisturizers, a randomized controlled trial. Br J Dermatol 2007; 156: 492–498. [CrossRef]
  15. Halkier-Sørensen L, Thestrup-Pedersen K. The efficacy of a moisturizer (locobase) among cleaners and kitchen assistants during everyday exposure to water and detergents. Contact Dermatitis 1993; 29: 266–271. [CrossRef]
  16. Held E, Lund H, Agner T. Effect of different moisturizers on SLS-irritated human skin. Contact Dermatitis 2001; 44: 229–234. [CrossRef]
  17. Held E, Sveinsdóttir S, Agner T. Effect of long-term use of moisturizer on skin hydration. Acta Derm Venereol 1999; 79: 49–51. [CrossRef]
  18. Ramsing DW, Agner T. Preventive and therapeutic effect of a moisturizer. An experimental study of human skin. Acta Derm Venereol 1997; 77: 335–337. [CrossRef]
  19. Zachariae C, Held E, Johansen JD, Menné T, Agner T. Effect of a moisturizer on skin susceptIbility to NiCl2. Acta Derm Venereol 2003; 83: 93–97. [CrossRef]
  20. Long CC, Finlay AY. The finger-tip unit – a new practical measure. Clin Exp Dermatol 1991; 16: 444–447. [CrossRef]
  21. Tupker RA, Willis C, Berardesca E, Lee CH, Fartasch M, Agner T, Serup J. Guidelines on sodium lauryl sulfate (SLS) exposure tests. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 1997; 37: 53–69. [CrossRef]
  22. Jungersted JM, Hellgren LI, Drachmann T, Jemec GBE, Agner T. Validation of the cyanoacrylate method for the collection of stratum corneum in human skin for lipid analysis. Skin Pharmacol Physiol 2010; 23: 62–67. [CrossRef]
  23. Pinagoda J, Tupker RA, Agner T, Serup J. Guidelines for transepidermal water loss (TEWL) measurement. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 1990; 22: 164–178. [CrossRef]
  24. Fullerton A, Fischer T, Lahti A, Wilhelm KP, Takiwaki H, Serup J. Guidelines for measurement of skin colour and erythema. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 1996; 35: 1–10. [CrossRef]
  25. Agache P, Mary S, Muret P, Matta AM, Humbert P. Assessment of the water content of the stratum corneum using a sorption–desorption test. Dermatology 2001; 202: 308–313. [CrossRef]
  26. Motta S, Monti M, Sesana S, Caputo R, Carelli S, Ghidoni R. Ceramide composition of the psoriatic scale. Biochim Biophys Acta 1993; 1182: 145–151. [CrossRef]
  27. Jemec GB, Na R. Hydration and plasticity following long-term use of a moisturizer: a single-blind study. Acta Derm Venereol 2002; 82: 322–324. [CrossRef]

Share with your friends





Actions


Abstract

Full text

PDF

Supplementary


There is no supplementary for this article.

Print information


Volume 91, Issue 3

DOI: 10.2340/00015555-1064

Pages: 290-294

View at PubMed